±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1640  |  »Ø¸´: 2

cat_cat_fish

Ìú³æ (СÓÐÃûÆø)

[½»Á÷] Postdoctoral Fellow and/or visiting scholar positons at UIowa ÒÑÓÐ2È˲ÎÓë

Two Postdoctoral Fellow positions and/or visiting scholar positions are available immediately in Drs. Bing-Hua Jiang (https://www.ncbi.nlm.nih.gov/pubmed/?term=jiang+bh) and Ling-Zhi Liu's (https://www.ncbi.nlm.nih.gov/pubmed/?term=liu+ling-zhi) groups in the Department of Pathology, the University of Iowa (UIowa), Iowa City,IA 52242, USA. Our research areas of interests are to identify novel signaling pathways and mechanisms that regulate tumor initiation, angiogenesis, and development. We will focus on the study and mechanism of initiation and progression of human cancers that are induced by environmental factors, such as metal carcinogens.  Through this program, we will identify new mechanisms, biomarkers, and/or therapeutic targets for cancer prevention and treatment in the future. Our group initially finds that PI3K signaling pathway, ROS and miRNAs play important roles in tumor angiogenesis and drug resistance.  For more information, please read some of our related work in Cancer Res. 67(22):10823, 2007; EMBO Rep.  13(12):1116, 2012; Autophagy.  11(2):373, 2015; Oncogene.  34(43):5482, 2015; Toxicol Sci. 134(1):26, 2013; Environ Health Perspect. 122(3):255, 2014; Oncotarget. 7(14):17805, 2016. For the Postdoctoral Fellow position, a Ph.D. degree in molecular biology or other biomedical science with good research experience is required. We greatly appreciate the application from candidates from minority groups or with good experience in tumor microenvironment, database analysis, or/and 1-4 years of training in USA. For visiting scholar, we hope the candidates have techniques of molecular biology such as cell culture, RNA, DNA and protein detection. We have enough funding support for these position in our department.  Our Institute offers excellent research environment, and competitive salary based on experience and effort. For consideration, please send your curriculum vitae, and the names of three references to: Dr. Ling-Zhi Liu at ling-zhi-liu@uiowa.edu.

Selected publication:
Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
He J, Yu JJ, Xu Q, Wang L, Zheng JZ, Liu LZ, Jiang BH.
Autophagy. 2015;11(2):373-84.

Chronic arsenic exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1¦Á/COX-2 pathway.
He J, Wang M, Jiang Y, Chen Q, Xu S, Xu Q, Jiang BH, Liu LZ.
Environ Health Perspect. 2014 Mar;122(3):255-61.

Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.
Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X, Yu J, Guan X, Jiang BH, Liu LZ.
Biochim Biophys Acta. 2013 Feb;1829(2):239-47.

A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B, Peiper SS, Jiang BH, Liu LZ.
J Mol Cell Biol. 2013 Feb;5(1):3-13. doi: 10.1093/jmcb/mjs049.

Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation.
He J, Xu Q, Jing Y, Agani F, Qian X, Carpenter R, Li Q, Wang XR, Peiper SS, Lu Z, Liu LZ, Jiang BH.
EMBO Rep. 2012 Dec;13(12):1116-22.

Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis.
Liu LZ, Zheng JZ, Wang XR, Jiang BH.
Cancer Res. 2008 Oct 1;68(19):8183-8. doi: 10.1158/0008-5472.CAN-08-0819.

AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
Liu LZ, Zhou XD, Qian G, Shi X, Fang J, Jiang BH.
Cancer Res. 2007 Jul 1;67(13):6325-32.
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

¹¤×÷»ú»á

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

fdhuangjun

Ìú³æ (³õÈëÎÄ̳)

2Â¥2017-10-25 15:46:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

longshe2014

Òø³æ (СÓÐÃûÆø)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
²»´í£¬·Ãѧʱ¼äÒªÇó¶à¾ÃÄØ

·¢×ÔСľ³æAndroid¿Í»§¶Ë
3Â¥2017-10-28 23:07:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ cat_cat_fish µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] »¯Ñ§¹¤³Ìµ÷¼Á289 +14 yangæÃ 2026-04-07 15/750 2026-04-07 12:31 by 1018329917
[¿¼ÑÐ] 285Çóµ÷¼Á +16 ŶßϺôo 2026-04-04 16/800 2026-04-07 12:31 by 1018329917
[¿¼ÑÐ] 297Çóµ÷¼Á +13 GENJIOW 2026-04-07 14/700 2026-04-07 12:25 by 1018329917
[¿¼ÑÐ] Çóµ÷¼Á +5 С›g 2026-04-03 5/250 2026-04-06 22:45 by 875465
[¿¼ÑÐ] 287Çóµ÷¼Á +3 ͨÐÅѧ˶081000 2026-04-03 4/200 2026-04-06 21:03 by going home
[¿¼ÑÐ] 385·Ö ÉúÎïѧ£¨071000£©Çóµ÷¼Á +12 qf626 2026-04-01 12/600 2026-04-06 17:36 by 52305043001
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +5 ´Þwj 2026-04-05 5/250 2026-04-06 15:40 by lin-da
[¿¼ÑÐ] ²ÄÁÏר˶283Çóµ÷¼Á +17 ÊÔÊÔ¿´ß 2026-04-04 18/900 2026-04-06 09:24 by 286640313
[¿¼ÑÐ] 308Çóµ÷¼Á +3 ÖÕ²»ËÆ´Óǰ 2026-04-05 3/150 2026-04-05 22:23 by hemengdong
[¿¼ÑÐ] 307·Ö²ÄÁÏרҵÇóµ÷¼Á +7 Hllºú 2026-04-05 7/350 2026-04-05 18:47 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] һ־Ըͬ¼Ã´óѧ323·Ö£¨080500£©Çóµ÷¼Á +8 yikeniu 2026-04-01 8/400 2026-04-05 18:15 by cql1109
[¿¼ÑÐ] 328·Öµ÷¼Á +6 ÃÅmen 2026-04-04 6/300 2026-04-05 13:40 by imissbao
[¿¼ÑÐ] µ÷¼Á +3 ºÃºÃ¶ÁÊé¡£ 2026-04-02 3/150 2026-04-05 13:02 by arrow8852
[¿¼ÑÐ] [µ÷¼ÁÐÅÏ¢]085408¹âµçÐÅÏ¢ Çóµ÷¼Á ×Ü·Ö291·ÖÊýÒ»Ó¢Ò» +3 iz11az 2026-04-02 3/150 2026-04-04 19:09 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏÅ©090401£¬268£¬Çóµ÷¼Á +5 һľÄñÈ» 2026-04-04 5/250 2026-04-04 17:07 by babysonlkd
[¿¼ÑÐ] 320µ÷¼Á +4 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-03 4/200 2026-04-03 21:40 by lbsjt
[¿¼ÑÐ] 283Çóµ÷¼Á +3 jiouuu 2026-04-03 4/200 2026-04-03 13:28 by jiouuu
[¿¼ÑÐ] 0856³õÊÔ324·ÖÇóµ÷¼Á +6 ÏëÉÏѧÇóµ÷ 2026-04-01 6/300 2026-04-02 11:42 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 310·ÖÇóµ÷¼Á +4 ³É¹¦Éϰ¶wang 2026-04-01 4/200 2026-04-01 20:35 by liu823948201
[¿¼ÑÐ] 303·Ö 0807ѧ˶Çóµ÷¼Á +3 TYC3632 2026-04-01 3/150 2026-04-01 19:24 by lwk2004
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û